Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Pediatr Crit Care Med ; 24(12 Suppl 2): S61-S75, 2023 02 01.
Artigo em Inglês | MEDLINE | ID: mdl-36661436

RESUMO

OBJECTIVE: To provide evidence for the Second Pediatric Acute Lung Injury Consensus Conference updated recommendations and consensus statements for clinical practice and future research on invasive mechanical ventilation support of patients with pediatric acute respiratory distress syndrome (PARDS). DATA SOURCES: MEDLINE (Ovid), Embase (Elsevier), and CINAHL Complete (EBSCOhost). STUDY SELECTION: We included clinical studies of critically ill patients undergoing invasive mechanical ventilation for PARDS, January 2013 to April 2022. In addition, meta-analyses and systematic reviews focused on the adult acute respiratory distress syndrome population were included to explore new relevant concepts (e.g., mechanical power, driving pressure, etc.) still underrepresented in the contemporary pediatric literature. DATA EXTRACTION: Title/abstract review, full text review, and data extraction using a standardized data collection form. DATA SYNTHESIS: The Grading of Recommendations Assessment, Development and Evaluation approach was used to identify and summarize relevant evidence and develop recommendations, good practice statements and research statements. We identified 26 pediatric studies for inclusion and 36 meta-analyses or systematic reviews in adults. We generated 12 recommendations, two research statements, and five good practice statements related to modes of ventilation, tidal volume, ventilation pressures, lung-protective ventilation bundles, driving pressure, mechanical power, recruitment maneuvers, prone positioning, and high-frequency ventilation. Only one recommendation, related to use of positive end-expiratory pressure, is classified as strong, with moderate certainty of evidence. CONCLUSIONS: Limited pediatric data exist to make definitive recommendations for the management of invasive mechanical ventilation for patients with PARDS. Ongoing research is needed to better understand how to guide best practices and improve outcomes for patients with PARDS requiring invasive mechanical ventilation.


Assuntos
Lesão Pulmonar Aguda , Síndrome do Desconforto Respiratório , Adulto , Humanos , Criança , Síndrome do Desconforto Respiratório/terapia , Respiração Artificial , Respiração com Pressão Positiva , Volume de Ventilação Pulmonar
2.
Rev Iberoam Micol ; 37(3-4): 87-93, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-33279388

RESUMO

BACKGROUND: The epidemiology of candidemia has changed over the last decades and varies widely among geographic areas. AIMS: We examined in children (aged 0-14) with candidemia the trends in the incidence rate of this infection, as well as the clinical characteristics of the patients, in order to optimize the prognosis and the control measures of this serious disease. METHODS: A retrospective cohort study of candidemia in the period 2011-2018 in the neonatal intensive care unit (NICU), pediatric ICU (PICU) and pediatric wards of a tertiary hospital, was conducted. The clinical course, Candida species isolated, antifungal susceptibility, outcome and incidence rates were analyzed and compared. RESULTS: We diagnosed 68 episodes of candidemia in 62 children, 48% occurred in the NICU, 31% in the PICU and 21% in pediatric wards. Candida albicans was the most frequent species isolated in NICU infants (53%), and Candida parapsilosis predominated among PICU patients (59%) and pediatric wards (50%). One third of NICU infants had invasive candidiasis (IC), most of them having extremely low birth weight (ELBW) (35%). All isolates were susceptible to the antifungal administered. Over time, the incidence of candidemia decreased in the PICU (from 2.2 to 0.3 episodes/1000 patient-days, OR=0.6; 95%CI 0.5-0.8), whereas in the NICU and in the wards remained stable. Mortality occurred mostly in NICU patients (26%), predominated in ELBW infants and did not change over time. CONCLUSIONS: The higher incidence and mortality of candidemia and IC observed in preterm infants requires a continuous evaluation of practices and diagnostic methods which will allow improving the prognosis of this most vulnerable population.


Assuntos
Candidemia , Candidíase , Antifúngicos/farmacologia , Antifúngicos/uso terapêutico , Candidemia/tratamento farmacológico , Candidemia/epidemiologia , Candidíase/tratamento farmacológico , Criança , Humanos , Incidência , Lactente , Recém-Nascido , Recém-Nascido Prematuro , Estudos Retrospectivos , Centros de Atenção Terciária
3.
Rev. iberoam. micol ; 37(3/4): 87-93, jul.-oct. 2020. tab, graf
Artigo em Inglês | IBECS | ID: ibc-200358

RESUMO

BACKGROUND: The epidemiology of candidemia has changed over the last decades and varies widely among geographic areas. AIMS: We examined in children (aged 0-14) with candidemia the trends in the incidence rate of this infection, as well as the clinical characteristics of the patients, in order to optimize the prognosis and the control measures of this serious disease. METHODS: A retrospective cohort study of candidemia in the period 2011-2018 in the neonatal intensive care unit (NICU), pediatric ICU (PICU) and pediatric wards of a tertiary hospital, was conducted. The clinical course, Candida species isolated, antifungal susceptibility, outcome and incidence rates were analyzed and compared. RESULTS: We diagnosed 68 episodes of candidemia in 62 children, 48% occurred in the NICU, 31% in the PICU and 21% in pediatric wards. Candida albicans was the most frequent species isolated in NICU infants (53%), and Candida parapsilosis predominated among PICU patients (59%) and pediatric wards (50%). One third of NICU infants had invasive candidiasis (IC), most of them having extremely low birth weight (ELBW) (35%). All isolates were susceptible to the antifungal administered. Over time, the incidence of candidemia decreased in the PICU (from 2.2 to 0.3 episodes/1000 patient-days, OR=0.6; 95%CI 0.5-0.8), whereas in the NICU and in the wards remained stable. Mortality occurred mostly in NICU patients (26%), predominated in ELBW infants and did not change over time. CONCLUSIONS: The higher incidence and mortality of candidemia and IC observed in preterm infants requires a continuous evaluation of practices and diagnostic methods which will allow improving the prognosis of this most vulnerable population


ANTECEDENTES: La epidemiología de la candidemia varía con el tiempo y entre las áreas geográficas. OBJETIVOS: Se ha estudiado en niños (0-14 años) con candidemia la evolución de la tasa de incidencia y las características clínicas de los pacientes para optimizar el pronóstico y las medidas de control de esta grave enfermedad. MÉTODOS: Se llevó a cabo un estudio de cohorte retrospectivo de los casos de candidemia en la unidad de cuidados intensivos neonatales (UCIN), UCI pediátrica (UCIP) y salas pediátricas de un hospital terciario, entre los años 2011 y 2018. Se compara el curso clínico, las especies de Candida, la sensibilidad antifúngica y las tasas de incidencia. RESULTADOS: Se diagnosticaron 68 episodios de candidemia en 62 niños; el 48% de ellos tuvieron lugar en UCIN, el 31% en UCIP y el 21% en salas pediátricas. Candida albicans fue la especie más frecuente en UCIN (53%), y Candida parapsilosis predominó en UCIN (59%) y salas pediátricas (50%). Un tercio de los bebés de la UCIN tenía candidiasis invasora (CI) y la mayoría presentaba extremado bajo peso al nacimiento (EBPN) (35%). Con el tiempo, la incidencia de candidemia disminuyó en la UCIP (de 2,2 a 0,3 episodios/1.000 días/paciente, OR: 0,6; IC 95%: 0,5-0,8), mientras que en la UCIN y en las salas permaneció estable. La mortalidad se produjo principalmente en pacientes de UCIN (26%), predominó en lactantes EBPN y no cambió con el tiempo. CONCLUSIONES: La mayor incidencia y mortalidad de la candidemia y CI observadas en lactantes prematuros requiere una evaluación continua de prácticas y métodos de diagnóstico que permitan mejorar el pronóstico de esta población más vulnerable


Assuntos
Humanos , Masculino , Feminino , Recém-Nascido , Lactente , Pré-Escolar , Criança , Adolescente , Candidemia/epidemiologia , Candidemia/microbiologia , Centros de Atenção Terciária , Antifúngicos/uso terapêutico , Estudos Retrospectivos , Candidemia/tratamento farmacológico , Estudos de Coortes , Fatores de Risco , Espanha/epidemiologia , Incidência
4.
Rev. chil. anest ; 49(6): 784-794, 2020. ilus, graf
Artigo em Espanhol | LILACS | ID: biblio-1512213

RESUMO

Acute respiratory distress syndrome (ARDS) is characterized by an increase in the intrapulmonary shunt (measured by the PaO2/FiO2 ratio) caused by bilateral alveolar-interstitial infiltrates which are not fully explained by fluid overload. However, there are some ARDS cases which present severe hypoxemia without clear lung infiltrates. An example of this, which has generated great controver- sy, is the infection caused by SARS-CoV-2. Understanding the pathophysiology of hypoxemia is absolutely crucial in order to establish the most appropriate therapeutic strategy for each patient. In the case of a severe hypoxemia (PaO/ FiO2 < 200 which represents a shunt greater than 30%) with a chest X-ray (or CT) without clear and extensive bilateral infiltrates, it is important to consider that the shunt can be caused due to vascular involvement. This shunt could be explained two ways: an increase in pulmonary vascular resistance (PVR), which generates a right-to-left shunt through the patent foramen ovale (PFO), or an alteration of the hypoxic pulmonary vasoconstriction reflex (HPV). The HPV reflex is activated in an attempt to redistribute the vascular flow to better ventilated areas. However, there are some situations (such as viral infections) that can alter this reflex and worsen the hypoxemia. The concomitant use of vasoactive drugs (such as inhaled nitric oxide) and vasopressors (such as dopa- mine or norepinephrine) has been proposed with the aim of reducing PVR and the flow through the PFO; or to redistribute the flow to better ventilated areas if an alteration of the RVP is suspected.


Un síndrome de distrés respiratorio agudo (SDRA) se caracteriza por un incremento del intrapulmonar (medido por el cociente PaO2/FiO2) causado por una afectación alveolo-intersticial bilateral no explicada por sobrecarga hídrica. Sin embargo, hay casos de SDRA que presentan una marcada hipoxemia sin claros infiltrados pulmonares. Un ejemplo de este caso, que ha generado gran controversia, es la infección por SARS-CoV-2. El entendimiento de la fisiopato- logía de la hipoxemia es absolutamente clave para establecer la estrategia terapéutica más adecuada en cada paciente. Ante una hipoxemia grave (PaO2/FiO2 < 200 que representa un superior al 30%) y con una radiografía de tórax (o con TAC) sin claros y extensos infiltrados bilaterales, el podría deberse a una afectación vascular. Esto podría explicarse por dos causas: un aumento de las resistencias vasculares pulmonares (RVP), que genera un derecha- izquierda a través del foramen oval permeable (FOP) o una alteración del reflejo de vasoconstricción pulmonar hipóxico (VPH). El reflejo de VPH se activa en un intento por redistribuir el flujo vascular hacia las zonas mejor ventiladas. Sin embargo, existen situaciones (como infecciones víricas) que pueden alterar dicho reflejo y agravar la hipoxemia. Se ha propuesto el uso concomitante de fármacos vasoactivos (como el óxido nítrico inhalado) y vasopresores (como do- pamina o noradrenalina) con el objetivo de disminuir las RVP y el flujo a través del FOP; o para redistribuir el flujo a zonas mejor ventiladas si se sospecha una alteración del RVP.


Assuntos
Humanos , Síndrome do Desconforto Respiratório do Recém-Nascido/fisiopatologia , Vasoconstrição/fisiologia , SARS-CoV-2 , COVID-19/fisiopatologia , Hipóxia/fisiopatologia
5.
J Pediatr Intensive Care ; 2(3): 111-119, 2013 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-31214432

RESUMO

Generally, monitoring of hypoxemia has been always based on partial pressure of arterial oxygen to fraction of inspired oxygen ratio; recently it was confirmed a good correlation between this ratio and a non-invasive alternative ratio of oxygen saturation to fraction of inspired oxygen (SF ratio = SpO2/FiO2). The SF ratio has been studied and validated, especially in the intubated patients, however studies monitoring patients treated with non-invasive ventilation (NIV) are lacking. The aim of the study was to determine if the SF ratio is a reliable predictive factor for failure of NIV in pediatric patients diagnosed with hypoxemic acute respiratory failure due to pneumonia. A five year retrospective study with consecutive sampling of patients diagnosed with hypoxemic acute respiratory failure due to pneumonia, admitted to the pediatric intensive care unit in a university hospital and treated with NIV was conducted. Physiological and ventilator variables were collected before starting NIV and at 2, 8 and 12 hours of treatment, and the corresponding SF ratios calculated. Thirty-four patients were studied. NIV failed in seven patients. Significant differences in SF ratio were observed between the successful and unsuccessful patients at the onset, 2 and 12 hours of treatment. Multivariable analysis revealed the SF ratio at two hours to be an independent predictor of NIV failure (odds ratio = 0.96, 95% confidence intervals 0.93-0.99; P = 0.015). Area Under Receiver Operating Characteristic curve = 0.90 (95% confidence interval = 0.79 to 1.000), optimal cut off value for SF at 2 hours ≤ 189; sensitivity = 86%, specificity = 74%. In conclusion, the SF ratio of 189 or less at 2 hours of NIV seems to be useful for predicting NIV failure in this cohort.

7.
Crit Care Med ; 40(12): 3238-45, 2012 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-22990455

RESUMO

OBJECTIVES: The incidence and outcome of the acute respiratory distress syndrome in children are not well-known, especially under current ventilatory practices. The goal of this study was to determine the incidence, etiology, and outcome of acute respiratory distress syndrome in the pediatric population in the setting of lung protective ventilation. DESIGN: A 1-yr, prospective, multicenter, observational study in 12 geographical areas of Spain (serving a population of 3.77 million ≤ 15 yrs of age) covered by 21 pediatric intensive care units. SUBJECTS: All consecutive pediatric patients receiving invasive mechanical ventilation and meeting American-European Consensus Criteria for acute respiratory distress syndrome. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Data on ventilatory management, gas exchange, hemodynamics, and organ dysfunction were collected. A total of 146 mechanically ventilated patients fulfilled the acute respiratory distress syndrome definition, representing a incidence of 3.9/100,000 population ≤ 15 yrs of age/yr. Pneumonia and sepsis were the most common causes of acute respiratory distress syndrome. At the time of meeting acute respiratory distress syndrome criteria, mean PaO2/FIO2 was 99 mm Hg ± 41 mm Hg, mean tidal volume was 7.6 mL/kg ± 1.8 mL/kg predicted body weight, mean plateau pressure was 27 cm H2O ± 6 cm H2O, and mean positive end-expiratory pressure was 8.9 cm ± 2.9 cm H2O. Overall pediatric intensive care unit and hospital mortality were 26% (95% confidence interval 19.6-33.7) and 27.4% (95% confidence interval 20.8-35.1), respectively. At 24 hrs, after the assessment of oxygenation under standard ventilatory settings, 118 (80.8%) patients continued to meet acute respiratory distress syndrome criteria (PaO2/FIO2 104 mm Hg ± 36 mm Hg; pediatric intensive care units mortality 30.5%), whereas 28 patients (19.2%) had a PaO2/FIO2 >200 mm Hg (pediatric intensive care units mortality 7.1%) (p = .014). CONCLUSIONS: This is the largest study to estimate prospectively the pediatric population-based acute respiratory distress syndrome incidence and the first incidence study performed during the routine application of lung protective ventilation in children. Our findings support a lower acute respiratory distress syndrome incidence and mortality than those reported for adults. PaO2/FIO2 ratios at acute respiratory distress syndrome onset and at 24 hrs after onset were helpful in defining groups at greater risk of dying (clinical trials registered with http://www.clinicaltrials.gov; NCT 01142544).


Assuntos
Avaliação de Resultados em Cuidados de Saúde , Síndrome do Desconforto Respiratório/epidemiologia , Lesão Pulmonar Aguda/epidemiologia , Pré-Escolar , Feminino , Humanos , Incidência , Lactente , Unidades de Terapia Intensiva Pediátrica , Masculino , Auditoria Médica , Pneumonia/complicações , Estudos Prospectivos , Respiração Artificial/estatística & dados numéricos , Síndrome do Desconforto Respiratório/etiologia , Síndrome do Desconforto Respiratório/fisiopatologia , Espanha/epidemiologia
8.
J Pediatr Intensive Care ; 1(4): 193-200, 2012 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-31214408

RESUMO

OBJECTIVE: To study patients diagnosed with bronchiolitis receiving ventilatory support with non-invasive ventilation (NIV) according to a chronologic classification: initial support (i-NIV), rescue post-extubation (r-NIV) and elective post-extubation (e-NIV); and to identify predictive factors of failure for each group. Prospective observational study (January 2004-December 2009), including all the patients with bronchiolitis admitted to pediatric intensive care unit and receiving ventilatory support with NIV. Clinical data collected at 0 (pre-NIV), 1, 2, 8, 12, 24 h of treatment were analyzed. Need for intubation was considered as NIV failure. NIV was successful in 65.8% of 152 cases included. Success rates were as follows: i-NIV (52.2%); r-NIV (72.2%); and e-NIV (90.9%) (Anova P < 0.000). Bi-level modes had higher efficacy (73%) than continuous positive airway pressure (61.5%) (Fisher's-test P = 0.049). Predictive factors of success in i-NIV group were inspired fraction of oxygen (FiO2) at 2 h, P = 0.003, higher pulse oximeter saturation (SpO2)/FiO2 values at 2 h (P = 0.009), and SpO2/FiO2 - 12 h (P = 0.05), lower heart rate (HR) at 12 h (P = 0.01), lower partial pressure of carbon dioxide (PCO2) previous to NIV (P = 0.009) and HR decrease-12 h (P = 0.008), In e-NIV: respiratory rate (RR)-1 h (P = 0.02), RR decrease-1 h (P = 0.006) and higher SpO2/FiO2 - 24 h (P = 0.01); in r-NIV: SpO2/FiO2 - 12 h (P = 0.04), lower HR-2 h (P = 0.03) and HR-8 h (P = 0.01). Multivariate analysis identified the groups as an independent variable (P = 0.04) but didn't show any significant value in any of the analyzed groups. Separate evaluation is advisable for i-NIV, r-NIV and e-NIV.

9.
Med. clín (Ed. impr.) ; 116(10): 396-396, mar. 2001.
Artigo em Es | IBECS | ID: ibc-12437

RESUMO

No disponible


Assuntos
Funções Verossimilhança
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...